NEW YORK (GenomeWeb News) – Horizon Discovery said today it has inked a worldwide distribution deal covering Haplogen's haploid cellular models.

Under the terms of the deal, effective immediately, customers will be able to purchase directly from Horizon, Haplogen's Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. Horizon said the deal is its first covering the distribution of another company's products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Gene drives might run into biological resistance, the Economist reports.